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Abstract
Background: Horses infected with Leptospira present several clinical disorders, one of them being
recurrent uveitis. A common endpoint of equine recurrent uveitis is blindness. Serovar pomona has
often been incriminated, although others have also been reported. An antigenic relationship
between this bacterium and equine cornea has been described in previous studies. A leptospiral
DNA fragment that encodes cross-reacting epitopes was previously cloned and expressed in
Escherichia coli.
Results: A region of that DNA fragment was subcloned and sequenced. Samples of leptospiral
DNA from several sources were analysed by PCR with two primer pairs designed to amplify that
region. Reference strains from serovars canicola, icterohaemorrhagiae, pomona, pyrogenes, wolffi,
bataviae, sentot, hebdomadis and hardjo rendered products of the expected sizes with both pairs of
primers. The specific DNA region was also amplified from isolates from Argentina belonging to
serogroups Canicola and Pomona. Both L. biflexa serovar patoc and L. borgpetersenii serovar tarassovi
rendered a negative result.
Conclusions: The DNA sequence related to the antigen mimicry with equine cornea was not
exclusively found in serovar pomona as it was also detected in several strains of Leptospira belonging
to different serovars. The results obtained with L. biflexa serovar patoc strain Patoc I and L.
borgpetersenii serovar tarassovi strain Perepelicin suggest that this sequence is not present in these
strains, which belong to different genomospecies than those which gave positive results. This is an
interesting finding since L. biflexa comprises nonpathogenic strains and serovar tarassovi has not
been associated clinically with equine uveitis.
Background
Leptospirosis is a widespread disease that affects wild and
domestic animals as well as humans [1]. Animals which
have recovered from acute leptospirosis may develop a
carrier condition, shedding leptospires in their urine [2].
Horses infected with Leptospira present several clinical dis-
orders, one of them being recurrent uveitis or iridocyclitis
[3,4]. In equine recurrent uveitis (ERU), episodes of acute
anterior uveitis are separated by quiescent periods of vari-
able duration [5]. Acute signs include blepharospasm, lac-
rimation, photophobia, myosis, corneal edema and
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vascularisation, aqueous flare and hypopyon, although
no single case shows these signs all together. With repeat-
ed attacks, the severity of the lesions becomes more pro-
nounced. The inflammatory process may lead to anterior
or posterior synechiae, cataract, iris atrophy, retinal de-
tachment, lens luxation and corneal opacity [3,5].
A common endpoint of ERU is blindness. Horses with
uveitis associated with leptospiral seroreactivity are at in-
creased risk of developing blindness with respect to horses
which uveitis was attributable to other causes [6]. Serovar
pomona has often been incriminated, although others
have also been reported.
Parma et al.[7] showed that equine cornea and Leptospira
share partial antigenic identity. In fact, corneal opacity
was provoked by inoculating horses either with killed
Leptospira or equine cornea. Based on these findings, ERU
is considered an organ-specific autoimmune disease [8].
The epitopes shared between Leptospira and equine cornea
belong to a protein structure located inside this bacterium
[9]. A leptospiral DNA fragment that encodes cross-react-
ing epitopes was cloned and expressed in Escherichia coli as
a β -galactosidase-fusion protein [10]. This clone, isolated
by expression screening with a polyclonal serum raised
against equine cornea proteins, encodes a 90 kDa protein
of serovar pomona. Antibodies directed against this lept-
ospiral antigen recognized a 66 kDa equine corneal pro-
tein. These findings suggest that an immune response to
that leptospiral antigen participates in pathogenesis of
equine uveitis.
Therefore, it would be interesting to investigate whether
this region is spread in the genomes of several serovars of
Leptospira.
Before 1989, taxonomy of the leptospires distributed
these bacteria between two species, Leptospira interrogans
(pathogenic) and L. biflexa (saprophytic) comprising over
200 serovars [11] on the basis of surface agglutinins. For
convenience, antigenically related serovars are organized
into serogroups.
On the basis of studies on DNA homology, polymorphic
patterns and rRNA typing, the taxonomy of Leptospira has
been recently reorganized into 17 genomospecies: L. inter-
rogans sensu stricto (hereafter called L. interrogans), L. bifl-
exa sensu stricto (hereafter called L. biflexa),  L.
borgpetersenii, L. weilii, L. noguchii, L. santarosai, L. inadai,
L. wolbachii, L. meyeri, L. parva, L. kirschneri, L. fainei and 5
new genomospecies one of which was named L. alexan-
deri[12–15]. However, until simpler DNA-based identifi-
cation methods are developed and validated, it will be
necessary for clinical laboratories to retain the serological
classification of pathogenic leptospires for the foreseeable
future [16].
In the present study, we began with the analysis of serov-
ars of Leptospira by PCR with two primer pairs designed to
amplify the region antigenically related to equine cornea.
Results and Discussion
A region of the leptospiral DNA fragment that encodes
epitopes involved in the antigenic cross-reactivity between
this bacterium and equine cornea was subcloned and se-
quenced. The obtained sequence was deposited in the
GenBank database under accession no. AY046585. Two
primer pairs were designed from the sequence to amplify
that region by PCR: S3a/S3b and S4a/S4b, which produce
253 and 152 bp PCR amplicons, respectively.
Several samples of leptospiral DNA, from reference strains
and isolates from Argentina, were analysed by PCR with
these primers (Table 1). Reference strains from serovars
canicola, icterohaemorrhagiae, pomona, pyrogenes, wolffi, bat-
aviae, sentot, hebdomadis and hardjo rendered products of
the expected sizes with both pairs of primers (Fig. 1). The
specific DNA region was also amplified from isolates from
Argentina belonging to serogroups Canicola and Pomo-
na. A single product was obtained in all cases of positive
amplification.
Both L. biflexa serovar patoc and L. borgpetersenii serovar
tarassovi rendered a negative result when analysed with the
two pairs of primers S3a/S3b and S4a/S4b (Fig. 1).
Another set of primers (G1/G2 and B64-I/ B64-II) previ-
ously described [17,18] was used as a positive control of
leptospiral DNA (results not shown). With these primers,
L. borgpetersenii and all L. interrogans strains here men-
tioned were amplified, suggesting that the failure to am-
plify the sequence related antigenically to equine cornea
from L. borgpetersenii serovar tarassovi was not due to tem-
plate degradation or to the presence of PCR inhibitors
Therefore, this strain is not likely to carry this sequence or
presents variations in DNA fine structure that prevent PCR
primer annealing.
As primers G1/G2 and B64-I/ B64-II are specific for path-
ogenic leptospires, the presence of leptospires in the aliq-
uot taken from the culture of L. biflexa serovar patoc was
determined by microscopic observation.
These results suggest that in the nonpathogenic strain an-
alysed, the sequence related to the antigen mimicry with
equine cornea is not present. In addition, this sequence
could not be detected either in one of the pathogenic
strains. Interestingly, it belongs to a different genomospe-
cies (L. borgpetersenii) than the other pathogenic strainsBMC Microbiology 2002, 2 http://www.biomedcentral.com/1471-2180/2/3
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Figure 1
Agarose gel electrophoresis of PCR products amplified from reference strains of Leptospira serovars pomona, pyrogenes, ictero-
haemorrhagiae, tarassovi, wolffi, canicola and patoc using primers S3a and S3b (A) or S4a and S4b (B). Positive control: recom-
binant E. coli carrying the leptospiral fragment antigenically related to equine cornea (E. coli 3.12). Negative control: distilled
water (without sample DNA). Lane MW contains DNA molecular size marker (100 bp DNA Ladder, Promega, Madison, Wl).
Arrows indicate PCR products.
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studied which are all L. interrogans. It should be noted
that, so far as we know, serovar tarassovi has not been as-
sociated with ERU.
According to Faine [2], there has been a tendency to ex-
trapolate and generalize a conclusion to all leptospires
from observations on one or few strains studied. But now-
adays, newer advances on genetic groupings dictates that
much of the conventionally accepted knowledge has to be
studied critically again with modern techniques to ascer-
tain the extent of genotypic and phenotypic variation.
This study contributes to the knowledge of the distribu-
tion of a DNA sequence, which is present in L. biflexa se-
rovar pomona, among different serovars of Leptospira.
Additional studies with different strains of L. borgpetersenii
will be necessary to know if this sequence is not present in
this genomospecies. It would be also interesting to inves-
tigate whether corneal epitopes crossreactive with this
bacterium are present in different breeds of horses and in
other species of the family Equidae (as ERU is also the
leading cause of blindness in mules).
Conclusions
A DNA sequence of sevovar pomona related to the antigen
mimicry with equine cornea was detected in several
strains of Leptospira belonging to different serovars, in-
cluding reference strains and isolates from Argentina.
Therefore, this sequence is not exclusively present in sero-
var pomona.
The results obtained with L. biflexa serovar patoc strain Pa-
toc I and L. borgpetersenii serovar tarassovi strain Perepe-
licin suggest that this sequence is not present in these
strains, which belong to different genomospecies than
those which gave positive results. This is an interesting
finding since L. biflexa comprises nonpathogenic strains
and serovar tarassovi has not been associated clinically
with ERU.
Materials and Methods
Bacteria and culture conditions
Reference strains of Leptospira used in this publication are
listed in Table 1. Six clinical isolates from Argentina were
also studied (3 belonging to serogroup Canicola and 3 to
Pomona). Leptospires were maintained in Fletcher medi-
um [19].
Sample preparation
Aliquots were taken from cultures, diluted 1/10 in water
and boiled for 10 min. Five microliters were used as the
template for PCR amplification.
Primers
Primer sequences for the indicated region were as follows.
S3a (sense):
5' GCGGATATGGGAAGCTTAGAAACT 3'
S3b:
5' CCGAAACTGTAGCCGAAGAAGAAA 3'
S4a (sense):
5' TCCTTTTGGCGATTTAGCAGAA 3'
S4b:
5' CGTGTCCGGAGTAGAAGTGAATGT 3'
Table 1: Reference strains of Leptospira tested in this study
GENOMOSPECIES (*) SEROGROUP SEROVAR STRAIN
L. interrogans Canicola canicola Hond Utrecht IV
L. interrogans Icterohaemorrhagiae icterohaemorrhagiae RGA
L. interrogans Pomona pomona Pomona
L. interrogans Pyrogenes pyrogenes Salinem
L. borgpetersenii Tarassovi tarassovi Perepelicin
L. interrogans Sejroe wolffi 3705
L. biflexa Semaranga patoc Patoc I
L. interrogans Bataviae bataviae Van Tienen
L. interrogans Djasiman sentot Sentot
L. interrogans Hebdomadis hebdomadis Hebdomadis
L. interrogans Sejroe hardjo Hardjoprajitno
(*) as indicated in Leptospira Molecular Genetics Server  [http://www.pasteur.fr/recherche/Leptospira] BMC Microbiology 2002, 2 http://www.biomedcentral.com/1471-2180/2/3
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PCR amplification
PCR was performed in a final volume of 25 µl containing
50 mM KCl, 10 mM Tris-HCl pH 9.0, 0.1% (v/v) Triton X-
100, 1.5 mM MgCl2, 200 µM each dNTP, 0.5 µM each
primer (either S3a and S3b or S4a and S4b), 1U Taq DNA
polymerase.
PCR amplifications were performed as follows: initial de-
naturation at 94°C for 2 min, followed by 30 cycles of de-
naturation at 94°C for 1 1/2 min, annealing at 66°C
(primer pair S3a/S3b) or 57°C (primer pair S4a/S4b) for
1 1/2 min, extension at 72°C for 2 min and a final exten-
sion at 72°C for 5 min. Reaction products were analysed
in a 1.5% agarose gel stained with ethidium bromide.
Another set of primers (G1/G2 and B64-I/ B64-II) previ-
ously described [17,18] was used as a positive control of
leptospiral DNA. The reaction mix was constituted by 50
mM KCl, 10 mM Tris-HCl pH 9.0, 0.1% (v/v) Triton X-
100, 2 mM MgCl2, 0.01% (m/v) gelatine, 250 µM each
dNTP, 0.5 µM each of the four primers, 0.5 U Taq DNA
polymerase in a final volume of 25 µl. PCR amplifications
were performed as described [18].
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